- Global Pharma News & Resources

Asklepios Kliniken: Asklepios successfully acquires RHÖN-KLINIKUM AG

DGAP-News: Asklepios Kliniken / Key word(s): Investment/Joint Venture
09.07.2020 / 10:00
The issuer is solely responsible for the content of this announcement.

Basis for strategic partnership: Asklepios successfully acquires RHÖN-KLINIKUM AG

  • Asklepios acquires 28,464,866 RHÖN shares as part of the voluntary public takeover offer
  • Together with the RHÖN founder, this gives Asklepios 92.58% of the voting rights
  • Kai Hankeln, CEO of the Asklepios Group: "Based on our strong, joint position, we will now break new ground for advanced medical care in Germany as partners"

Hamburg, 9 July 2020. Asklepios Kliniken GmbH & Co. KGaA successfully concluded the voluntary public takeover offer to the shareholders of RHÖN-KLINIKUM AG as part of its objective of creating a strategic partnership. By the end of the additional acceptance period on 6 July 2020, altogether 28,464,866 shares were tendered to Asklepios at the offer price of EUR 18.00 in cash per RHÖN share. In total, this gives Asklepios a share in the voting rights of approximately 84.98%. As announced in February, Asklepios will contribute these shares to the new joint venture established together with RHÖN founder Eugen Münch. Münch himself contributed a further approximately 7.6% of RHÖN shares to the joint venture through HCM SE, which he controls. After the conclusion of the transaction, the joint venture holds 92.58% of voting rights. At the end of May the German Federal Cartel Office had already granted merger control clearance for Asklepios' voluntary public takeover and plans to pool the shares, without any conditions. RHÖN-KLINIKUM AG will remain an independent company within the Asklepios group after the transaction has been concluded.

"By successfully concluding the transaction, together we can now begin to make our vision of healthcare provision in Germany a reality. RHÖN and Asklepios will complement each other strategically, learn from each other and, in doing so, position themselves optimally for long-term, sustained success - for the benefit of patients and all employees," said Kai Hankeln, CEO of the Asklepios Group. "Based on our strong, joint position, we will now break new ground for advanced medical care in Germany as partners. With the University Hospital of Giessen and Marburg lighting the way, RHÖN can play a key role in this."

Hafid Rifi, Chief Financial Officer at Asklepios, commented: "United under one roof, we will take full advantage of the Group's economies of scale for each individual hospital. Our first step now is to take stock of the situation and together examine whether and to what extent specific synergy potential can be harnessed. Savings from these economies of scale are to remain in the company so that they may be used to create new jobs and invest in modern patient care. In addition, we want to help RHÖN hire additional (intensive care) nursing staff, for example at the University Hospital of Giessen and Marburg, in order to further improve patient care and reduce employees' workload. Of course, all current collective agreements at RHÖN will remain."

Together with RHÖN, Asklepios wants to actively promote digitalisation at its hospitals and in the hospital sector as a whole, further consolidating its position as a pioneer of digital healthcare. Especially when it comes to issues such as electronic patient records, discharge management and expanding digital psychological therapy, a coordinated approach by the two hospital groups offers significant potential for optimisation. RHÖN is pursuing exciting initiatives in this area, including working on telemedicine with Medgate and AI-based revenue assurance with Tiplu, which we can strengthen together as a group.

New, digital approaches reinforce the expansion of outpatient treatment, allowing us to work across sectors in a way that benefits patients. Coming together as a group does not only further improve patient care - it also reduces employees' workload. In addition, we are also committed to developing pioneering healthcare concepts such as capitation models, which increase planning reliability for hospitals, hospital staff and health insurance companies alike.

About Asklepios

Asklepios Kliniken is one of the leading private operators of hospitals and healthcare facilities in Germany. The hospital group stands for highly qualified care for its patients, with a clear commitment to medical quality, innovation and social responsibility. On this basis, Asklepios has grown dynamically since it was founded almost 35 years ago. The Group currently has around 160 healthcare facilities throughout Germany, including acute care hospitals for all levels of care, specialist clinics, psychiatric and forensic facilities, rehabilitation clinics, nursing homes and medical service centres. In the 2019 financial year, 2.5 million patients were treated at the Asklepios Group's facilities. The company has more than 49,000 employees.

IR contact
Mirjam Constantin
Investor Relations
Asklepios Kliniken GmbH & Co. KGaA
Debusweg 3
61462 Königstein-Falkenstein
Tel: +49 61 74 90-1166
Fax: +49 61 74 90-1110

PR contact:
Rune Hoffmann
Head of Corporate Communications & Marketing
Asklepios Kliniken GmbH & Co. KGaA
Rübenkamp 226
22307 Hamburg
Tel.: +49 40 1818-82 6630
Fax: +49 40 1818-82 6639

Visit Asklepios online, on Facebook or on YouTube:

Pflege-Blog: "Wir sind Pflege"

09.07.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

Editor Details

Last Updated: 09-Jul-2020